Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Debt / NOTE 0.599% 8/0
-
Unit price / market price
-
$1.05
-
Total 13F principal
-
$354,379,300
-
Principal change
-
-$44,050,000
-
Total reported value
-
$370,772,018
-
Number of holders
-
47
-
Value change
-
-$45,882,457
-
Number of buys
-
15
-
Number of sells
-
22
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 0.599% 8/0 as of Q4 2021
As of 31 Dec 2021 BIOMARIN PHARMACEUTICAL INC - NOTE 0.599% 8/0 had 47 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $354,379,300 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included PFM Health Sciences, LP, ADVENT CAPITAL MANAGEMENT /DE/, ROYAL BANK OF CANADA, SHENKMAN CAPITAL MANAGEMENT INC, MACKAY SHIELDS LLC, MORGAN STANLEY, STATE STREET CORP, BANK OF AMERICA CORP /DE/, Thrivent Financial for Lutherans, and BlackRock Inc..
This table shows 48 bond principal holders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.